Recent advances in the brain targeting of neuropharmaceuticals by chemicaldelivery systems

Citation
N. Bodor et P. Buchwald, Recent advances in the brain targeting of neuropharmaceuticals by chemicaldelivery systems, ADV DRUG DE, 36(2-3), 1999, pp. 229-254
Citations number
161
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ADVANCED DRUG DELIVERY REVIEWS
ISSN journal
0169409X → ACNP
Volume
36
Issue
2-3
Year of publication
1999
Pages
229 - 254
Database
ISI
SICI code
0169-409X(19990405)36:2-3<229:RAITBT>2.0.ZU;2-G
Abstract
Brain-targeted chemical delivery systems represent a general and systematic method that can provide localized and sustained release for a variety of t herapeutic agents including neuropeptides. By using a sequential metabolism approach, they exploit the specific trafficking properties of the blood-br ain barrier and provide site-specific or site-enhanced delivery. After a br ief description of the design principles, the present article reviews a num ber of specific delivery examples (zidovudine, ganciclovir, lomustine benzy lpenicillin, estradiol, enkephalin, TRH, kyotorphin), together with represe ntative synthetic routes, physicochemical properties, metabolic pathways, a nd pharmacological data. A reevaluated correlation for more than 60 drugs b etween previously published in vivo cerebrovascular permeability data and o ctanol/water partition coefficients is also included since it may be useful in characterizing the properties of the blood-brain barrier, including act ive transport by P-glycoprotein. (C) 1999 Elsevier Science BN. All rights r eserved.